» Articles » PMID: 8246614

The Incidence and Prevalence of Congestive Heart Failure in Rochester, Minnesota

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 1993 Dec 1
PMID 8246614
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Although congestive heart failure is a fairly common clinical syndrome and the societal costs associated with its care are high, relatively little is known about the incidence or prevalence of the condition in the community. Using the resources of the Rochester Epidemiology Project, we identified all 46 persons 0 through 74 years of age who had a new diagnosis of congestive heart failure during 1981 and all 113 persons with a prevalent diagnosis on Jan. 1, 1982, in the city of Rochester, Minnesota. After confirming the diagnosis in the medical record by using criteria similar to those in the Framingham study, we found the annual incidence of congestive heart failure to be 110 per 100,000 after adjusting for age. Incidence rates were higher among male than among female study subjects (157 versus 71 per 100,000). In both male and female subjects, the incidence generally increased with advancing age, reaching 1,618 per 100,000 and 981 per 100,000, respectively. Prevalence rates on Jan. 1, 1982, demonstrated similar patterns. Overall, the prevalence of congestive heart failure was higher among male than among female subjects (327 versus 214 per 100,000) and increased exponentially with advancing age, reaching almost 3% in both sexes. Survival after a diagnosis of congestive heart failure was extremely poor, with only 80% alive at 3 months and 66% at 1 year. These data underscore the effect of congestive heart failure in the community and provide estimates of the number of persons who might benefit from early intervention.

Citing Articles

Heart Failure With Preserved Ejection Fraction: An Evolving Understanding.

Tah S, Valderrama M, Afzal M, Iqbal J, Farooq A, Lak M Cureus. 2023; 15(9):e46152.

PMID: 37900404 PMC: 10613100. DOI: 10.7759/cureus.46152.


Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.

Larsen C, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J JAMA Netw Open. 2023; 6(2):e2254669.

PMID: 36735254 PMC: 9898820. DOI: 10.1001/jamanetworkopen.2022.54669.


Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF.

Simon J, Nemeth E, Nemes A, Husveth-Toth M, Radovits T, Foldes G Front Physiol. 2019; 10:690.

PMID: 31231242 PMC: 6558211. DOI: 10.3389/fphys.2019.00690.


Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China.

Guo L, Guo X, Chang Y, Yang J, Zhang L, Li T Int J Environ Res Public Health. 2016; 13(8).

PMID: 27483300 PMC: 4997456. DOI: 10.3390/ijerph13080770.


"Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Schranz D, Voelkel N Eur J Pediatr. 2016; 175(4):445-55.

PMID: 26895877 PMC: 4806719. DOI: 10.1007/s00431-016-2700-3.